Journal
PHARMACEUTICS
Volume 13, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13060908
Keywords
nanoparticles; nanostructured lipid carriers; ursolic acid; toxicity; visceral leishmaniasis
Categories
Funding
- Sao Paulo Research Foundation (FAPESP) [2016/10324-6, 2016/00468-0, 2018/04080-2, 2018/24077-6, HCFMUSP-LIM50]
- Applied Molecular Biosciences Unit-UCIBIO - national funds from FCT/MCTES [UID/Multi/04378/2019]
Ask authors/readers for more resources
Researchers successfully enhanced the activity of ursolic acid by entrapping it in nanostructured lipid carriers, showing leishmanicidal activity superior to conventional drugs. The treatment not only combats leishmaniasis, but also boosts immune response, protects spleen and liver, and normalizes hepatic and renal functions.
Ursolic acid, a triterpene produced by plants, displayed leishmanicidal activity in vitro and in vivo; however, the low solubility of this triterpene limits its efficacy. To increase the activity of ursolic acid (UA), this triterpene was entrapped in nanostructured lipid carriers (UA-NLC), physical-chemical parameters were estimated, the toxicity was assayed in healthy golden hamsters, and the efficacy of UA-NLC was studied in experimental visceral leishmanisis. UA-NLC exhibited a spherical shape with a smooth surface with a size of 266 nm. UA-NLC displayed low polydispersity (PDI = 0.18) and good colloidal stability (-29.26 mV). Hamsters treated with UA-NLC did not present morphological changes in visceral organs, and the levels of AST, ALT, urea and creatinine were normal. Animals infected with Leishmania (Leishmania) infantum and treated with UA-NLC showed lower parasitism than the infected controls, animals treated with UA or Amphotericin B (AmB). The therapeutic activity of UA-NLC was associated with the increase in a protective immune response, and it was associated with a high degree of spleen and liver preservation, and the normalization of hepatic and renal functions. These data indicate that the use of lipid nanoparticles as UA carriers can be an interesting strategy for the treatment of leishmaniasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available